Member Info for Saxondale

I must admit that when I bought these shares way back , with the thought that the only way I would relinquish them before the jackpot RNS would be for someone to prise them from my cold head hands , I didn't think that scenario would possibly be because of old age .

Partially explains why he cashed some shares in the other day - to diversify and make sure his family were shielded from any Bitcoin collapse if it were ever to happen . Very commendable - now he takes a riskier but far more lucrative salary .
I'm still learning here , but this CEO does seem like a man on a mission .
Great stuff

Yes owning Faron shares is quite similar to owning an old classic car ( mine was an MG Midget back in the day ! )

10 months of the year they gather dust , then for 2 months you actually get pleasure from owning them .
Likewise , its about the journey , not the destination ( and wherever you go , it takes longer than planned )
The fuel gauge is a bit sticky , and when you think its empty and tap the dial , it manages to sink even further .
But the owners club is full of cheery folk , and we always wave at each other when we pass !

I always thought mine would make me more attractive to the opposite sex . That never worked , but these shares will if they hit £20 lol

When Markku talked of this shareholder value window , I never wrote a date in my diary , as it was a phrase that was put out by Markku as an indication of what he hoped would happen in the near term , given what they knew at the time , and where the company finances were .

This was done before the soluble Clever 1 discovery , and before the recent placing however .

Those Cohorts must be coming along now , and a few must surely now have been fully analysed . To the point at which Markku hinted that shareholders would finally see some action .

What I am undecided at the moment is - was the soluble Clever1 discovery such a 'remarkable' find , that it has made them rethink what they have - hence the placing to carry on trialing before they make any deals ?

I'm not sure , but I'm leaning towards thinking that they now have something even more valuable potentially , and it was worth a further placing to allow them to get some results on the more frequent dosing of Clevegen in trials .

If the trials prove up the theory that Bexmarilimab suppresses soluble Clever1 as well as acting on the solid tumours , then the price tag goes up even further .

Its a shame that the SP always slides back like an Austin Allegro parked on a hill with the handbrake on , and that good news only pushes us up to the place where we started , but we really now are getting into the month or so when the BIG one will land .

We've never been in a situation with so many P2 cohorts coming to completion , and with such positive encouragement from bodies such as the EIC , and the FDA .

Traumakine is doing its thing , and is financially secure now in getting a P3 result one way or another .

Manufacturing of IFN beta1a is coming along well - and regardless of Traumakine - that new manufacturing technique is going to be in high demand .
Clevegen manufacturing also preparing to be scaled up to commercial levels .

This really could be the last chance to lay your hands on some Faron shares at this price ( and I mean that in a good way lol )

now thats a man that could do with a nebuliser

Big fan of Bob Flemming myself

Came across this video yesterday , about an hour , but worth a listen if you have time .
Old hands here probably already watched , but I'm catching up fast .

It was only half way through that I realised it was recorded in 2016 .

Everything he is saying then becomes almost prophetic - uncanny .

And as if we didn't already know how things get engineered...

https://www.youtube.com/watch?v=WmuiAY2WiIU&t=2701s

I think I guessed £1.51 . For some reason i've always had that in the back of my mind when I top up . Topped up yesterday at 23.5p . Hopefully that will be a decision I class as one of my better ones , compared to say buying some at 36p , just a week or so before the infamous share sell catastrophe . Either way , both tops ups will pay off , its just whether i have to wait 5 days or 5 years to see it lol

I won't waste any more space on Traumakine here , but Hew , yes the WHO would not disclose any data to Faron , but the WHO report conclusions were based solely on subcutaneous delivery ( of which there were I believe over 5000 doses given ) .

Only going on Reuters , I think it was just Interferon that was mentioned . Possibly SNG , possibly another IFN B1b trial . Not us I don't think , although REMAP-CAP does have some hospitals in France enrolled .
Either way - any good interferon news is good news .

With Hibiscus first dosing not yet announced , I think the next leg up here will be Bexmarilimab related - news on which could drop any day .

Just for the record , Farons drug did not fail with the WHO , it was never used . What was used was Mercks subcutaneous injection of Interferon Beta1a . Faron never got a look in .
The upshot ( excuse the pun) is that subcutaneous IFN Beta1a was written off as a possible contender .

Intravenous delivery ( Faron ) - is now being trialed in REMAP-CAP ( with no steroid mixing as that is the drugs achilles heel ) . It never got much of a look in on REMAP until recently , as they were giving every patient steroids as standard care - hence voiding the patient as a Traumakine candidate .
But it is getting its own trial in the USA now , actually being compared directly against steroids , and in reverse of previous care , will be administered FIRST , before steroids .

Not as universally useable as SNG001 , but it still may play a valid part in the fight against Covid , and particularly ARDS , when the lungs get too full of fluid for a nebuliser to be effective .

Farons Traumakine is only on REMAP-CAP in Europe ( some french hospitals , but mostly UK , and so far not widely taken up due to steroid use )
USA Hibiscus trial yet to start for Faron , so don't think the French connection is Traumakine .

Anybody know much about this trial - in France using nebulised Interferon Beta 1b
Do you think this is what they are talking about ?

Not SNG - but either way - nebulised interferon

https://clinicaltrials.gov/ct2/show/NCT04356495?term=interferon&recrs=a&cond=Covid19&cntry=FR&draw=2&rank=5

Finland to go into 3 week lockdown from March 8th .
Should again focus attention on companies doing their best to produce effective therapies .
I'm sure Faron will get some more media exposure over there .

Always happens . I just thought this time would be different - imminent update due on Clevegen.
Anyway - topped up , so I suppose I should be grateful .
Loads of Pharma stocks got walloped yesterday for no reason . Trouble is our SP is like a stiff door , needs a good kick to get it moving again .

If we had no news , and no placing , we'd probably be at this SP due to speculation as to our cash balance , so at least we know we have money in the bank to achieve the short term goals , and hopefully get some of the P2 cohorts to deal making positions .

We all know Faron are working busily behind the scenes .

I think there was some sort of reset yesterday on small cap shares with the trading platforms regarding margin calls etc - NCYT got hammered , and that was on their list of shares . Don't know about Faron , but I think much use was made of that causing SP's across many shares to fall where people were being forced to liquidate their positions . A lot are bouncing back up today .

Many small cap Pharmas getting a pasting today , various reasons . Time to look around and pick up a few bargains if you know what you are looking at . Had another bite here and at SNG .
Bexmarilimab success not hinged on whether Boris or Mat know your uncle , and now USA is key target for both Farons future .
Added to daughters ISA today too . Investing in the future .

Yep just added another £2k , and into Faron too . Hold tight for a few weeks - great rewards to come :-)

Dr. Eric Lander, the director of the Broad Institute of MIT and Harvard University, will co-lead both offices.

Good job were getting an office in Boston too then .

Getting here has been a long time coming , but couldn't be at a more opportune moment Zum .

At least the price of scrap is going up lol

I got in here at average 2p , after the initial explosion .
Only a few grand - as I'd not really researched the company , so just get a toe in .
I'd never heard of Trevor Brown etc , although I soon got up to speed .
Gareth really did ( and/or does ) have a cracking product . I would have bought 100 if available .
But then all the comedy RNS's etc .
The PI voting made me think the company really had won the day - new members on BOD , changing of the guard etc .
But today just made me sigh . A real shame .

I really thought this product could be a real breakthrough -
It may be a ploy , like many of the other RNS's have been , in order to keep the price down for those in the know to mop them up , soon to be followed by a mysteriously positive one perhaps , but to be honest I have better things to do with my money than pin them on that sort of management .

So out I came - no financial loss really , but just a bit saddened that something which if actually produced , would be a real benefit to many people , is being dragged into the mire due to money grabbing and feather nesting .

This may all come good , and I hope it does for Gareth , and the shareholders who invested on his behalf , but for me , I'd rather place it into a company with a few more scruples .

They just don't pass the smell test at the moment .

Rant over - I wish you all the best , and I really hope it comes good .